Showing 1 - 6 results of 6 for search 'Alexander T. Haug', query time: 0.03s Refine Results
  1. 1
    Pantoprazole Decreases Cell Viability and Function of Human Osteoclasts In Vitro

    Pantoprazole Decreases Cell Viability and Function of Human Osteoclasts In Vitro by Markus Prause, Claudine Seeliger, Marina Unger, Elizabeth Rosado Balmayor, Martijn van Griensven, Alexander Tobias Haug

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography

    Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography by Walter Koch, Christoph J. Auernhammer, Julia Geisler, Christine Spitzweg, Clemens C. Cyran, Harun Ilhan, Peter Bartenstein, Alexander R. Haug

    Published 2014-06-01
    Get full text
    Article
  3. 3
    Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI—Compared with [<sup>18</sup>F]FDG PET/MRI

    Imaging Inflammation in Atherosclerosis with CXCR4-Directed [<sup>68</sup>Ga]PentixaFor PET/MRI—Compared with [<sup>18</sup>F]FDG PET/MRI by Xia Lu, Raffaella Calabretta, Wolfgang Wadsak, Alexander R. Haug, Marius Mayerhöfer, Markus Raderer, Xiaoli Zhang, Jingle Li, Marcus Hacker, Xiang Li

    Published 2022-07-01
    Get full text
    Article
  4. 4
    Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors

    Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumo... by Johannes Zellmer, Hsi-Yu Yen, Lena Kaiser, Franz Josef Gildehaus, Guido Böning, Katja Steiger, Marcus Hacker, Peter Bartenstein, Andrei Todica, Alexander R. Haug, Harun Ilhan

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer

    Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer by Tim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, Michael Weber, Bernhard Grubmüller, Gero Kramer, Shahrokh F. Shariat, Markus Mitterhauser, Stefan Schmitl, Chrysoula Vraka, Alexander R. Haug, Marcus Hacker, Markus Hartenbach, Sazan Rasul

    Published 2021-09-01
    Get full text
    Article
  6. 6
    Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI

    Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI by Clemens P. Spielvogel, Jing Ning, Kilian Kluge, David Haberl, Gabriel Wasinger, Josef Yu, Holger Einspieler, Laszlo Papp, Bernhard Grubmüller, Shahrokh F. Shariat, Pascal A. T. Baltzer, Paola Clauser, Markus Hartenbach, Lukas Kenner, Marcus Hacker, Alexander R. Haug, Sazan Rasul

    Published 2024-12-01
    Get full text
    Article

Search Tools: